A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Direct Induction of Hemogenic Endothelium and Blood by Overexpression of Transcription Factors in Human Pluripotent Stem Cells

7.2K views

⸱

DOI:

10.3791/52910

⸱

December 3rd, 2015

 ,  , 

In This Article

Summary

This protocol describes the efficient induction of hemogenic endothelium and multipotential hematopoietic progenitors from human pluripotent stem cells via the forced expression of transcription factors.

Abstract

During development, hematopoietic cells arise from a specialized subset of endothelial cells, hemogenic endothelium (HE). Modeling HE development in vitro is essential for mechanistic studies of the endothelial-hematopoietic transition and hematopoietic specification. Here, we describe a method for the efficient induction of HE from human pluripotent stem cells (hPSCs) by way of overexpression of different sets of transcription factors. The combination of ETV2 and GATA1 or GATA2 TFs is used to induce HE with pan-myeloid potential, while a combination of GATA2 and TAL1 transcription factors allows for the production of HE with erythroid and megakaryocytic potential. The addition of LMO2 to GATA2 and TAL1 combination substantially accelerates differentiation and increases erythroid and megakaryocytic cells production. This method provides an efficient and rapid means of HE induction from hPSCs and allows for the observation of the endothelial-hematopoietic transition in a culture dish. The protocol includes hPSCs transduction procedures and post-transduction analysis of HE and blood progenitors.

Introduction

The unique ability of human pluripotent stem cells (hPSCs) to self-renew and to differentiate into cells of the three germ layers, including blood, make them a valuable tool for the mechanistic studies of hematopoietic development, modeling of blood diseases, drug screening, toxicity studies, and the development of cellular therapies. Because blood formation in the embryo proceeds from hemogenic endothelium (HE) through an endothelial hematopoietic transition1,2, the generation of HE in cultures would be essential to study the molecular mechanisms regulating the endothelial to hematopoietic transition and hematopoietic specification. Current methods for stu....

Access restricted. Please log in or start a trial to view this content.

Protocol

1. Virus Preparations and Transcription Factor Combinations

  1. Prepare solutions with pSIN-EF1α lentiviral expression plasmid containing protein-coding DNA for ETV2, GATA1, GATA2, TAL1 and LMO2 (Table 1).
  2. Measure the concentration and purity of plasmid preparations used for lentiviral production by recording UV absorption with a spectrophotometer at 230 nm, 260 nm, and 280 nm. Note: DNA preparations demonstrating A260/280 and A260/230 values greater than 1.8 are generally considered good quality. Lower A260/280 values may indicate protein contamination, while lower A260/230 values indicate impurities with salts or ....

Access restricted. Please log in or start a trial to view this content.

Results

The schematic diagram of HE and blood induction from hPSCs by overexpression of transcription factors is shown in Figure 1. ETV2 with GATA1 or GATA2 combination induces pan-myeloid hematopoiesis, while a GATA2, TAL1 +/- LMO2 combination induces predominantly erythro-megakaryocytic hematopoiesis. Both TF combinations directly induced HE cells that subsequently transformed into blood progenitors with a distinct spectrum of hematopoietic differentiation. Differentiation of hPSCs from the pluripotent state t.......

Access restricted. Please log in or start a trial to view this content.

Discussion

The above-described method for hematopoietic differentiation of hPSCs by overexpression of TFs, represents a rapid and efficient approach for the generation of HE and myeloid and erytho-magakaryocytic progenitors from hESCs and iPSCs, thereby allowing the production of up to 30 millions blood cells from one million pluripotent stem cells10. This method exhibited consistent differentiation in multiple hESC and iPSCs lines10. During differentiation by ETV2 and GATA2, GATA1 factors as well as GATA2 and.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

I.S. is a founding shareholder and consultant for Cynata.

Acknowledgements

We thank Matt Raymond for editorial assistance. This work was supported by funds from the National Institute of Health (U01HL099773, R01HL116221, and P51 RR000167) and The Charlotte Geyer Foundation.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments

Table 1. Induction of hPSCs differentiation with trancription factors and analysis of hemogenic endothelium and blood cells.

pSIN4-EF1a-ETV2-IRES-Puro AddgenePlasmid #61061Lentiviral Vector
pSIN4-EF1a-GATA2-IRES-Puro AddgenePlasmid #61063Lentiviral Vector
pSIN4-EF1a-GATA1-IRES-Puro AddgenePlasmid #61062Lentiviral Vector
pSIN4-EF1a-TAL1-IRES-Puro AddgenePlasmid #61062Lentiviral Vector
pSIN4-EF1a-LMO2-IRES-Puro AddgenePlasmid #61064Lentiviral Vector
Hexadimethrine bromide (Polybrene) Sigma-Aldrich107689-10GCationic polymer used to increase the efficiency of infection
Y-27632 (Dihydrochloride) ROCK inhibitorSTEMCELL Technologies72302RHO/ROCK pathway inhibitor Inhibits ROCK
StemPro Accutase Cell Dissociation ReagentLife TechnologiesA11105-01Cell Dissociation Reagent
Incomplete (growth factor- free) culture medium                                              mTeSR1 Custom formulation WiCell Research Institute (Madison, WI)MCFSerum-free mTeSR1 medium without bFGF and TGFb 
human SCFPeprotech300-07Premium grade
human TPOPeprotech300-18Research grade
human FGF-basicPeprotech100-18BPremium grade
CD144 (VE-cad) FITCBD Biosciences560411Endothelial marker (FACS)
CD226 PEBD Biosciences338305Hematopoietic (FACS)
CD43 PEBD Biosciences560199Hematopoietic (FACS)
CD73 APCR&D SystemsFAB5795AEndothelial marker (FACS)
CD45 APCBD Biosciences555485Hematopoietic (FACS)
7AADLife TechnologiesA1310Live/Dead assay (FACS)
Paraformaldehyde Sigma-AldrichP6148-500GCell fixation 
Triton X-100 Sigma-AldrichT9284-500ML Permeabilization 
FBSFisher ScientificSH3007003Fetal bovine serum
Mouse anti-human CD43BD Biosciences551457Pure, primary antibody for Immunofluorescence (IF) staining
Rabbit anti-human VE-cadherinBenderMedSystemBMS158Primary (IF)
Anti-rabbit Alexa Fluor 488-conjugatedJacksonResearch715-486-152Secondary (IF)
Anti-mouse Alexa Fluor 594-conjugatedJacksonResearch715-516-150 Secondary (IF)
DAPI nucleic acid stainLife TechnologiesD1306 Live/Dead assay (IF)
Clonogenic medium MethoCult H4435 EnrichedSTEMCELL Technologies4435CFC-assay
Wright Stain solutionSigma -Aldrich32857Staining cytospins

Table 2. hPSCs culture.

Human Pluripotent Stem Cells (hPSCs) WiCell Research Institute (Madison, WI)hESCs (WA01, WA09) human Embryonic Stem cells; iPSCs (DF-19-9-7T, DF-4-3-7T) transgene-free induced Pluripotent Stem CellshPSCs are able to self-renew and to differentiate into cells of three germ layers
Complete serum-free medium for culture of hPSCs                                                    mTeSR1 media  WiCell Research Institute (Madison, WI)M500 Serum-free  medium with growth factors for feeder free culture of ESC/iPSCs
MatrigelBD Biosciences/ Corning 356234Matrix for maintenance of human ESC/iPSCs
DMEM/F-12, powder Life Technologies12500-062Basal Medium 
HyClone Dulbecco's PBS powderFisher ScientificdSH30013.04PBS
Dispase II, powderLife Technologies17105-041Neutral protease, Cell dissociation

Table 3. Primers for detection of virus genomic integration.

Primer's NameForward (Fwd)  5’ -->3’Reverse (Rev) 5’-->3’Discription 
pSIN EF1a FwdTTC CAT TTC AGG TGT CGT GA--EF1a promoter sequence
GATA1 Rev--TCC CTG TAG TAG GCC AGT GC Coding Region 
GATA2 Rev--GGT TGG CAT AGT AGG GGT TG Coding Region 
TAL1 Rev--AGG CGG AGG ATC TCA TTC TT Coding Region 
LMO2 Rev--GGC CCA GTT TGT AGT AGA GGC Coding Region 
ETV2 Rev--GAA CTT CTG GGT GCA GTA AC  Coding Region 

References

  1. Zape, J. P., Zovein, A. C. Hemogenic endothelium: origins, regulation, and implications for vascular biology. Semin Cell Dev Biol. 22, 1036-1047 (2011).
  2. Swiers, G., Rode, C., Azzoni, E., de Bruijn, M. F. A short history of hemogenic endothelium. Blood Cells, Mo....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Transcription Factor OverexpressionEndothelial Hematopoietic TransitionFlow Cytometry AnalysisLentiviral TransductionETV2 GATA1GATA2 TAL1LMO2 AdditionBlood Cell Differentiation